🇺🇸 FDA
Patent

US 7456199

Biphenyl compounds useful as muscarinic receptor antagonists

granted A61PA61P11/00A61P43/00

Quick answer

US patent 7456199 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P11/00, A61P43/00